Frontline BioVentures Company Profile

02:28 EST 23rd January 2020 | BioPortfolio

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life science and technology areas promoted by Chinese government. Frontline BioVentures is managed by a team of life science investment professionals with proven track records both internationally and domestically. The team has extensive experience in nurturing and scaling successful venture start-ups and is intimately familiar with the landscape of pharmaceutical, biotech/medtech and other life science industry in the country. Frontline BioVentures is currently managing a portfolio of 13 companies including Innovent, Hua Medicine, BioKangtai, Yikon Genomics, Jiecheng Medical, and Neusoft Medical. About Frontline BioVentures:

News Articles [220 Associated News Articles listed on BioPortfolio]

Beyond Next Aims To Boost Bioventures Over Japan Hurdles

Set up to support the development of bioventures in Japan, Tokyo’s Beyond Next Ventures sees itself as a broad-benefit accelerator...    

The latest advances from BioVentures for Global Health in Africa

Jennifer Dent speaks to ecancer at the Global Health Catalyst Summit 2019 at the Dana Farber Cancer Institute in Boston, Massachusetts about the progress of BioVentures for Global Health since her las...

Korea Eases Stock Rules To Help Bioventures Stay Listed, Focus On R&D

South Korea continues to ease stock market listing rules to help bioventures and other innovative companies sustain growth and focus...    

Frontline Setting in mRCC Continues to Evolve With Combo Regimens

Thai H. Ho, MD, PhD, discusses frontline treatment considerations in metastatic renal cell carcinoma, the utility of TKI monotherapy, and new combinations on the horizon. 

Predictive Biomarkers Needed for Immunotherapy Combo Choice in Frontline RCC

Ulka Vaishampayan, MD, discusses the role of frontline immunotherapy and patient selection in metastatic renal cell carcinoma. 

Frontline Standard in Myeloma Continues to Evolve

Sergio A. Giralt, MD, discusses the changing frontline treatment setting in multiple myeloma, how to determine transplant eligibility, and the utility of testing for minimal residual disease negativit...

Artificial Intelligence Can Be Biased. Here’s What You Should Know.

(Frontline) – Atificial intelligence has already started to shape our lives in ubiquitous and occasionally invisible ways. In its new documentary, In The Age of AI, FRONTLINE examines the promis...

Frontline Quadruplet Regimens Advance Treatment in Myeloma

Nina Shah, MD, discusses newer treatment options in the frontline and maintenance settings in multiple myeloma. 

PubMed Articles [85 Associated PubMed Articles listed on BioPortfolio]

Use of huddles among frontline staff in clinical settings: a scoping review protocol.

This scoping review aims to provide an overview of current evidence on huddles in health care settings involving frontline staff.

Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia.

Dasatinib, a potent Bcr-Abl tyrosine kinase inhibitor, is approved for the treatment of chronic-phase chronic myeloid leukemia (CML-CP) in the frontline and salvage settings. Notable side effects incl...

Empowerment of Frontline Leaders in an Online Learning, Certificate Program.

To evaluate the effectiveness of an online learning, certificate program for frontline nurse leaders' sense of empowerment.

Optimal management of mantle cell lymphoma in the primary setting.

: The management of mantle cell lymphoma (MCL) has significantly improved since the use of intensified induction and autologous stem cell transplant consolidation. Evolving developments in minimal res...

Updates in Treatment Strategies for Hodgkin Lymphoma.

Several options are available for frontline treatment of advanced-stage Hodgkin lymphoma (HL) and treatment of relapsed HL, each with inherent advantages and disadvantages. Clinicians must balance ris...

Clinical Trials [75 Associated Clinical Trials listed on BioPortfolio]

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

The primary objective of the present study is to evaluate the long-term observation, in terms of overall survival, of adult Ph+ ALL patients treated frontline with the sequential administr...

Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline

Primary Objective: - To evaluate the efficacy (combined morphologic and flow remissions) of a combination of fludarabine, cyclophosphamide and multiple dose rituximab as frontline...

Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

Gastric low-grade mucosa-associated lymphoid tissue lymphoma (MALToma) is associated with Helicobacter pylori (HP) infection, and around 70% of these tumors can be cured by HP eradication ...

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Delta-Like Protein 3-Expressing Extensive Stage Small Cell Lung Cancer

The purpose of the study is to test the effect of rovalpituzumab tesirine in the frontline treatment of small cell lung cancer (SCLC).

CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.

It has been recently reported that EATL type 1, but not refractory coeliac disease, strongly expressed CD30 and might benefit from brentuximab vedotin. Since the safety profile of the comb...

Companies [42 Associated Companies listed on BioPortfolio]

Frontline BioVentures

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...

TIO Bioventures

Tio Bioventures is a boutique venture creation firm focused on funding the advancement of biotechnology companies that are guided by its principles of employing rigorous, research-driven science to c...

BioVentures, Inc.

BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...

Alpine BioVentures

Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...

Advanced Pain Remedies

Headquartered near Research Triangle Park, NC, APR is majority owned and virtually run by Cato BioVentures. APR will work with Advanced Targeting Systems, Cato Research and Cato BioVentures to develop...

More Information about "Frontline BioVentures" on BioPortfolio

We have published hundreds of Frontline BioVentures news stories on BioPortfolio along with dozens of Frontline BioVentures Clinical Trials and PubMed Articles about Frontline BioVentures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Frontline BioVentures Companies in our database. You can also find out about relevant Frontline BioVentures Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record